company background image
LIFE

aTyr Pharma NasdaqCM:LIFE Stock Report

Last Price

US$2.37

Market Cap

US$68.8m

7D

-1.7%

1Y

-58.3%

Updated

30 Jan, 2023

Data

Company Financials +

LIFE Stock Overview

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States.

LIFE fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

aTyr Pharma, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for aTyr Pharma
Historical stock prices
Current Share PriceUS$2.37
52 Week HighUS$6.62
52 Week LowUS$2.00
Beta1.25
1 Month Change8.22%
3 Month Change-4.82%
1 Year Change-58.35%
3 Year Change-55.87%
5 Year Change-94.79%
Change since IPO-99.12%

Recent News & Updates

We're Keeping An Eye On aTyr Pharma's (NASDAQ:LIFE) Cash Burn Rate

Jan 04
We're Keeping An Eye On aTyr Pharma's (NASDAQ:LIFE) Cash Burn Rate

Recent updates

We're Keeping An Eye On aTyr Pharma's (NASDAQ:LIFE) Cash Burn Rate

Jan 04
We're Keeping An Eye On aTyr Pharma's (NASDAQ:LIFE) Cash Burn Rate

We Think aTyr Pharma (NASDAQ:LIFE) Needs To Drive Business Growth Carefully

May 10
We Think aTyr Pharma (NASDAQ:LIFE) Needs To Drive Business Growth Carefully

Is aTyr Pharma (NASDAQ:LIFE) In A Good Position To Deliver On Growth Plans?

Jan 24
Is aTyr Pharma (NASDAQ:LIFE) In A Good Position To Deliver On Growth Plans?

Is aTyr Pharma (NASDAQ:LIFE) In A Good Position To Deliver On Growth Plans?

Sep 23
Is aTyr Pharma (NASDAQ:LIFE) In A Good Position To Deliver On Growth Plans?

Is aTyr Pharma (NASDAQ:LIFE) In A Good Position To Deliver On Growth Plans?

May 22
Is aTyr Pharma (NASDAQ:LIFE) In A Good Position To Deliver On Growth Plans?

aTyr Pharma, Inc. (NASDAQ:LIFE) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Mar 25
aTyr Pharma, Inc. (NASDAQ:LIFE) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Did You Miss aTyr Pharma's (NASDAQ:LIFE) Impressive 103% Share Price Gain?

Feb 09
Did You Miss aTyr Pharma's (NASDAQ:LIFE) Impressive 103% Share Price Gain?

Shareholder Returns

LIFEUS BiotechsUS Market
7D-1.7%0.8%2.8%
1Y-58.3%7.1%-9.2%

Return vs Industry: LIFE underperformed the US Biotechs industry which returned 7.1% over the past year.

Return vs Market: LIFE underperformed the US Market which returned -9.2% over the past year.

Price Volatility

Is LIFE's price volatile compared to industry and market?
LIFE volatility
LIFE Average Weekly Movement7.0%
Biotechs Industry Average Movement12.2%
Market Average Movement6.9%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market2.8%

Stable Share Price: LIFE is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: LIFE's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200551Sanjay Shuklahttps://www.atyrpharma.com

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company’s lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. It is also developing ATYR2810, a fully humanized monoclonal antibody that is in preclinical development for the treatment of solid tumors.

aTyr Pharma, Inc. Fundamentals Summary

How do aTyr Pharma's earnings and revenue compare to its market cap?
LIFE fundamental statistics
Market CapUS$68.75m
Earnings (TTM)-US$46.38m
Revenue (TTM)n/a

0.0x

P/S Ratio

-1.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
LIFE income statement (TTM)
RevenueUS$0
Cost of RevenueUS$33.85m
Gross Profit-US$33.85m
Other ExpensesUS$12.52m
Earnings-US$46.38m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.60
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did LIFE perform over the long term?

See historical performance and comparison